Andreas Kjær

Andreas Kjær

Professor

ORCID: 0000-0002-2706-5547

Publication year:
All
51 - 53 out of 53Page size: 10
  1. 2021
  2. Published

    Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Zobel, E. H., Wretlind, A., Ripa, Rasmus Sejersten, Rotbain Curovic, V., von Scholten, B. J., Suvitaival, T., Hansen, T. W., Kjær, Andreas, Legido-Quigley, C. & Rossing, Peter, Sep 2021, In: BMJ open diabetes research & care. 9, 1, p. 1-9 e002395.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Hansen, T. W., Rossing, Peter & Størling, Joachim, 2021, In: Scientific Reports. 11, 18522.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effect of liraglutide on vascular inflammation evaluated by [64 cu]dotatate

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Curovic, V. R., Diaz, L. J., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Diagnostics. 11, 8, 11 p., 1431.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 Next

ID: 13402